Skip to main content
Top
Published in: Calcified Tissue International 3/2014

01-03-2014 | Original Research

Deletion of Serotonin 2B Receptor Provokes Structural Alterations of Mouse Dental Tissues

Authors: Sasha Dimitrova-Nakov, Anne Baudry, Yassine Harichane, Corinne Collet, Arnaud Marchadier, Odile Kellermann, Michel Goldberg

Published in: Calcified Tissue International | Issue 3/2014

Login to get access

Abstract

Rampant caries and periodontal diseases occur in patients treated with antidepressants such as serotonin reuptake inhibitors (SRIs; e.g., Prozac) which target the serotonin transporter (SERT). As the serotonin 2B receptor (5HT2BR) regulates SERT functionality and capacity to recognize SRIs, we investigated the potential role of 5HT2BR on dental tissues by exploiting 5HT2BR knockout (KO) mice. Compared to wild-type (WT) mice, several structural differences were identified in the teeth of KO mice. In the molar of KO mice, rod curvatures and twisting were altered compared to WT mice, suggesting involvement of 5HT2BR at early stages of enamel formation. The volume of the KO enamel layer was also reduced, and larger porosities were observed in the prismatic enamel, with smaller crystallite thickness. Crystallite pattern disorganization and occlusal abrasion were enhanced in female KO mice, indicating a sexual dimorphism. In the incisor, no difference was detected in the width of the enamel layer between KO and WT mice; however, enamel maturation differed in absence of 5HT2BR. Specifically, the outer aprismatic enamel border was 1.5- to 2-fold larger in KO compared to WT mice, together with a decreased etching pattern. Finally, although no noticeable difference was observed in dentin, the micro-CT three-dimensional pulp reconstruction evidenced a decrease in both length and width of dentin formation in the root canals of the KO versus WT mice. These data provide evidence that 5HT2BR-mediated signaling pathways are involved in enamel formation and dentinogenesis.
Literature
1.
2.
go back to reference Lauder JM, Wilkie MB, Wu C, Singh S (2000) Expression of 5HT(2A), 5HT(2B) and 5HT(2C) receptors in the mouse embryo. Int J Dev Neurosci 18:653–662PubMedCrossRef Lauder JM, Wilkie MB, Wu C, Singh S (2000) Expression of 5HT(2A), 5HT(2B) and 5HT(2C) receptors in the mouse embryo. Int J Dev Neurosci 18:653–662PubMedCrossRef
3.
go back to reference Gaspar P, Cases O, Maroteaux L (2003) The developmental role of serotonin: news from mouse molecular genetics. Nat Rev Neurosci 4:1002–1012PubMedCrossRef Gaspar P, Cases O, Maroteaux L (2003) The developmental role of serotonin: news from mouse molecular genetics. Nat Rev Neurosci 4:1002–1012PubMedCrossRef
4.
go back to reference Hoyer D, Hannon JP, Martin GR (2002) Molecular, pharmacological and functional diversity of 5HT receptors. Pharmacol Biochem Behav 71:533–554PubMedCrossRef Hoyer D, Hannon JP, Martin GR (2002) Molecular, pharmacological and functional diversity of 5HT receptors. Pharmacol Biochem Behav 71:533–554PubMedCrossRef
5.
go back to reference Nebigil CG, Etienne N, Schaerlinger B, Hickel P, Launay JM, Maroteaux L (2001) Developmentally regulated serotonin 5HT2B receptors. Int J Dev Neurosci 19:365–372PubMedCrossRef Nebigil CG, Etienne N, Schaerlinger B, Hickel P, Launay JM, Maroteaux L (2001) Developmentally regulated serotonin 5HT2B receptors. Int J Dev Neurosci 19:365–372PubMedCrossRef
6.
go back to reference Moiseiwitsch JRD, Lauder JM (1995) Serotonin regulates mouse cranial neural crest migration. Proc Natl Acad Sci USA 92:7182–7186PubMedCrossRef Moiseiwitsch JRD, Lauder JM (1995) Serotonin regulates mouse cranial neural crest migration. Proc Natl Acad Sci USA 92:7182–7186PubMedCrossRef
7.
go back to reference Moiseiwitsch JRD (2000) The role of serotonin and neurotransmitters during craniofacial development. Crit Rev Oral Biol Med 11:230–239PubMedCrossRef Moiseiwitsch JRD (2000) The role of serotonin and neurotransmitters during craniofacial development. Crit Rev Oral Biol Med 11:230–239PubMedCrossRef
8.
go back to reference Nebigil CG, Choi DS, Dierich A, Hickel P, Le Meur M, Messaddeq N, Launay J-M, Maroteaux L (2000) Serotonin 2B receptor is required for heart development. Proc Natl Acad Sci USA 97:9508–9513PubMedCrossRef Nebigil CG, Choi DS, Dierich A, Hickel P, Le Meur M, Messaddeq N, Launay J-M, Maroteaux L (2000) Serotonin 2B receptor is required for heart development. Proc Natl Acad Sci USA 97:9508–9513PubMedCrossRef
9.
go back to reference Choi D-S, Ward SJ, Messaddeq N, Launay J-M, Maroteaux L (1997) 5HT2B receptor-mediated serotonin morphogenetic functions in mouse cranial neural crest and myocardiac cells. Development 124:1745–1755PubMed Choi D-S, Ward SJ, Messaddeq N, Launay J-M, Maroteaux L (1997) 5HT2B receptor-mediated serotonin morphogenetic functions in mouse cranial neural crest and myocardiac cells. Development 124:1745–1755PubMed
10.
go back to reference Byrd KE, Sheskin TA (2001) Effects of post-natal serotonin levels on craniofacial complex. J Dent Res 80:1730–1735PubMedCrossRef Byrd KE, Sheskin TA (2001) Effects of post-natal serotonin levels on craniofacial complex. J Dent Res 80:1730–1735PubMedCrossRef
11.
go back to reference Launay JM, Schneider B, Loric S, Da Prada M, Kellermann O (2006) Serotonin transport and serotonin transporter-mediated antidepressant recognition are controlled by 5HT2B receptor signaling in serotonergic neuronal cells. FASEB J 20:1843–1854PubMedCrossRef Launay JM, Schneider B, Loric S, Da Prada M, Kellermann O (2006) Serotonin transport and serotonin transporter-mediated antidepressant recognition are controlled by 5HT2B receptor signaling in serotonergic neuronal cells. FASEB J 20:1843–1854PubMedCrossRef
12.
go back to reference Baudry A, Bitard J, Mouillet-Richard S, Locker M, Poliard A, Launay JM, Kellermann O (2010) Serotonergic 5HT(2B) receptor controls tissue-nonspecific alkaline phosphatase activity in osteoblasts via eicosanoids and phosphatidylinositol-specific phospholipase C. J Biol Chem 285:26066–26073PubMedCrossRef Baudry A, Bitard J, Mouillet-Richard S, Locker M, Poliard A, Launay JM, Kellermann O (2010) Serotonergic 5HT(2B) receptor controls tissue-nonspecific alkaline phosphatase activity in osteoblasts via eicosanoids and phosphatidylinositol-specific phospholipase C. J Biol Chem 285:26066–26073PubMedCrossRef
13.
go back to reference Westbroek I, Van Der Plas A, De Rooij KE, Klein-Nulends J, Nijweide PJ (2001) Expression of serotonin receptors in bone. J Biol Chem 276:28961–28968PubMedCrossRef Westbroek I, Van Der Plas A, De Rooij KE, Klein-Nulends J, Nijweide PJ (2001) Expression of serotonin receptors in bone. J Biol Chem 276:28961–28968PubMedCrossRef
14.
go back to reference Collet C, Schiltz C, Geoffroy V, Maroteaux L, Launay JM, De Vernejoul MC (2008) The serotonin 5HT2B receptor controls bone mass via osteoblast recruitment and proliferation. FASEB J 22:418–427PubMedCrossRef Collet C, Schiltz C, Geoffroy V, Maroteaux L, Launay JM, De Vernejoul MC (2008) The serotonin 5HT2B receptor controls bone mass via osteoblast recruitment and proliferation. FASEB J 22:418–427PubMedCrossRef
15.
go back to reference Gustafsson BI, Thommesen L, Stunes AK, Tommeras K, Westbroek I, Waldum HL, Slørdahl K, Tamburstuen MV, Reseland JE, Syversen U (2006) Serotonin and fluoxetine modulate bone cell function in vitro. J Cell Biochem 98:139–151PubMedCrossRef Gustafsson BI, Thommesen L, Stunes AK, Tommeras K, Westbroek I, Waldum HL, Slørdahl K, Tamburstuen MV, Reseland JE, Syversen U (2006) Serotonin and fluoxetine modulate bone cell function in vitro. J Cell Biochem 98:139–151PubMedCrossRef
16.
go back to reference Warden SJ, Robling AG, Haney EM, Turner CH, Bliziotes MM (2010) The emerging role of serotonin (5-hydroxytryptamine) in the skeleton and its mediation of skeletal effects of low-density lipoprotein receptor-related protein 5 (LRPS5). Bone 46:4–12PubMedCentralPubMedCrossRef Warden SJ, Robling AG, Haney EM, Turner CH, Bliziotes MM (2010) The emerging role of serotonin (5-hydroxytryptamine) in the skeleton and its mediation of skeletal effects of low-density lipoprotein receptor-related protein 5 (LRPS5). Bone 46:4–12PubMedCentralPubMedCrossRef
17.
go back to reference Verdel BM, Souverein PC, Egberts TCG, van Staa TP, Leufkens HGM, de Vries F (2010) Use of antidepressant drugs and risk of osteoporotic and non-osteoporotic fractures. Bone 47:604–609PubMedCrossRef Verdel BM, Souverein PC, Egberts TCG, van Staa TP, Leufkens HGM, de Vries F (2010) Use of antidepressant drugs and risk of osteoporotic and non-osteoporotic fractures. Bone 47:604–609PubMedCrossRef
18.
go back to reference Riksen EA, Stunes AK, Kalvik A, Gustafsson BI, Snead ML, Syversen U, Lyngstadaas SP, Reseland JE (2010) Serotonin and fluoxetine receptors are expressed in enamel organs and LS8 cells and modulate gene expression in LS8 cells. Eur J Oral Sci 118:566–573PubMedCrossRef Riksen EA, Stunes AK, Kalvik A, Gustafsson BI, Snead ML, Syversen U, Lyngstadaas SP, Reseland JE (2010) Serotonin and fluoxetine receptors are expressed in enamel organs and LS8 cells and modulate gene expression in LS8 cells. Eur J Oral Sci 118:566–573PubMedCrossRef
19.
go back to reference Friedlander A, Mahler ME (2001) Major depressive disorder. Psychopathology, medical management and dental implications. J Am Dent Assoc 132:629–638PubMedCrossRef Friedlander A, Mahler ME (2001) Major depressive disorder. Psychopathology, medical management and dental implications. J Am Dent Assoc 132:629–638PubMedCrossRef
20.
go back to reference Keene JJ Jr, Galasko GT, Land MF (2003) Antidepressant use in psychiatry and medicine: importance for dental practice. J Am Dent Assoc 134:71–79PubMedCrossRef Keene JJ Jr, Galasko GT, Land MF (2003) Antidepressant use in psychiatry and medicine: importance for dental practice. J Am Dent Assoc 134:71–79PubMedCrossRef
21.
go back to reference Harichane Y, Dimitrova-Nakov S, Marchadier A, Collet C, Baudry A, Vidal C, Kamoun-Goldrat A, Kellermann O, Goldberg M (2011) Enamel alterations in serotonin 2B receptor knockout mice. Eur J Oral Sci 119:177–184PubMedCrossRef Harichane Y, Dimitrova-Nakov S, Marchadier A, Collet C, Baudry A, Vidal C, Kamoun-Goldrat A, Kellermann O, Goldberg M (2011) Enamel alterations in serotonin 2B receptor knockout mice. Eur J Oral Sci 119:177–184PubMedCrossRef
22.
go back to reference Nikiforuk G, Fraser D (1979) Etiology of enamel hypoplasia and interglobular dentin: the role of hypocalcemia and hypophosphatasia. Metab Bone Dis Relat Res 2:17–23CrossRef Nikiforuk G, Fraser D (1979) Etiology of enamel hypoplasia and interglobular dentin: the role of hypocalcemia and hypophosphatasia. Metab Bone Dis Relat Res 2:17–23CrossRef
23.
go back to reference Gibson CW, Yuan ZA, Li Y, Daly B, Suggs C, Aragon MA, Alawi F, Kulkarni AB, Wright JT (2007) Transgenic mice that express normal and mutated amelogenins. J Dent Res 86:331–335PubMedCrossRef Gibson CW, Yuan ZA, Li Y, Daly B, Suggs C, Aragon MA, Alawi F, Kulkarni AB, Wright JT (2007) Transgenic mice that express normal and mutated amelogenins. J Dent Res 86:331–335PubMedCrossRef
24.
go back to reference Wright JT (2010) Consequences of amelogenin mutations: implications in amelogenesis imperfecta. In: Goldberg M (ed) Amelogenins: multifaceted proteins for dental and bone formation and repair. Bentham Science, Bussum, pp 88–98CrossRef Wright JT (2010) Consequences of amelogenin mutations: implications in amelogenesis imperfecta. In: Goldberg M (ed) Amelogenins: multifaceted proteins for dental and bone formation and repair. Bentham Science, Bussum, pp 88–98CrossRef
25.
go back to reference Wenzel A, Thylstrup A (1982) Dental fluorosis and localized enamel opacities in fluoride and nonfluoride Danish communities. Caries Res 16:340–348PubMedCrossRef Wenzel A, Thylstrup A (1982) Dental fluorosis and localized enamel opacities in fluoride and nonfluoride Danish communities. Caries Res 16:340–348PubMedCrossRef
26.
go back to reference Sasaki T, Goldberg M, Takuma S, Garant PR (1990) Cell biology of tooth enamel formation—functional electron microscopic monographs. Monogr Oral Sci 14:1–199 Karger, Basel, SwitzerlandPubMed Sasaki T, Goldberg M, Takuma S, Garant PR (1990) Cell biology of tooth enamel formation—functional electron microscopic monographs. Monogr Oral Sci 14:1–199 Karger, Basel, SwitzerlandPubMed
27.
go back to reference Lungova V, Radlanski RJ, Tucker AS, Renz H, Misek I, Matalova E (2011) Tooth–bone morphogenesis during postnatal stages of mouse first molar development. J Anat 218:699–716PubMedCrossRef Lungova V, Radlanski RJ, Tucker AS, Renz H, Misek I, Matalova E (2011) Tooth–bone morphogenesis during postnatal stages of mouse first molar development. J Anat 218:699–716PubMedCrossRef
28.
go back to reference Bartlett JD, Smith CE (2013) Modulation of cell–cell junctional complexes by matrix metalloproteinases. J Dent Res 92:10–17PubMedCrossRef Bartlett JD, Smith CE (2013) Modulation of cell–cell junctional complexes by matrix metalloproteinases. J Dent Res 92:10–17PubMedCrossRef
29.
go back to reference Goldberg M, Kulkarni AB, Young M, Boskey A (2011) Dentin: structure, composition and mineralization. The role of dentin ECM in dentin formation and mineralization. Front BioSci (Elite Ed) 3:711–735CrossRef Goldberg M, Kulkarni AB, Young M, Boskey A (2011) Dentin: structure, composition and mineralization. The role of dentin ECM in dentin formation and mineralization. Front BioSci (Elite Ed) 3:711–735CrossRef
30.
go back to reference Boyd LD, Dwyer JT, Papas A (1997) Nutritional implications of xerostomia and rampant caries caused by serotonin reuptake inhibitors: a case study. Nutr Rev 55:362–368PubMedCrossRef Boyd LD, Dwyer JT, Papas A (1997) Nutritional implications of xerostomia and rampant caries caused by serotonin reuptake inhibitors: a case study. Nutr Rev 55:362–368PubMedCrossRef
31.
go back to reference Mendes DC, Silva TF, Barros de Oliveira VM, Vieira LT, Haikal DS, Guimarães AL, De Paula AM (2013) Analysis of the normative conditions of oral health, depression and serotonin-transporter-linked promoter region polymorphisms in an elderly population. Geriatr Gerontol Int 13:98–106PubMedCrossRef Mendes DC, Silva TF, Barros de Oliveira VM, Vieira LT, Haikal DS, Guimarães AL, De Paula AM (2013) Analysis of the normative conditions of oral health, depression and serotonin-transporter-linked promoter region polymorphisms in an elderly population. Geriatr Gerontol Int 13:98–106PubMedCrossRef
32.
go back to reference Murphy DL, Lesch KP (2008) Targeting the murine serotonin transporter: insights into human neurobiology. Nat Rev Neurosci 9:85–96PubMedCrossRef Murphy DL, Lesch KP (2008) Targeting the murine serotonin transporter: insights into human neurobiology. Nat Rev Neurosci 9:85–96PubMedCrossRef
Metadata
Title
Deletion of Serotonin 2B Receptor Provokes Structural Alterations of Mouse Dental Tissues
Authors
Sasha Dimitrova-Nakov
Anne Baudry
Yassine Harichane
Corinne Collet
Arnaud Marchadier
Odile Kellermann
Michel Goldberg
Publication date
01-03-2014
Publisher
Springer US
Published in
Calcified Tissue International / Issue 3/2014
Print ISSN: 0171-967X
Electronic ISSN: 1432-0827
DOI
https://doi.org/10.1007/s00223-013-9810-y

Other articles of this Issue 3/2014

Calcified Tissue International 3/2014 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine